1. Pharmaceuticals and Drug Development

Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallo (tabelecleucel)

THOUSAND OAKS, Calif.–(BUSINESS WIRE) January 16, 2025 — Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for…

Comments to: Atara Biotherapeutics Provides Regulatory and Business Update on Ebvallo (tabelecleucel)

Login

Welcome to Life Science News!

"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.